(NOC)

Reporting relationship: Chair, CEO and President, Director
Issuer ticker: NOC
Reported as of: 11 Feb 2026
Net transaction value: -$10,434,296
SEC form: 4
Accepted by SEC: 13 Feb 2026, 16:16:33 UTC
Prior SEC filing: 10 Feb 2026
Next SEC filing: 19 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Jennifer C. McGarey, Attorney-in-Fact

Key filing fact

Kathy J. Warden filed Form 4 for NORTHROP GRUMMAN CORP /DE/ (NOC) on 13 Feb 2026.

Key facts

This page summarizes Kathy J. Warden's Form 4 filing for NORTHROP GRUMMAN CORP /DE/ (NOC).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 13 Feb 2026, 16:16.

Change

Previous filing in this sequence was filed on 10 Feb 2026.
Current net transaction value: -$10,434,296.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001559112 Primary reporting owner

Warden Kathy J

Relationship: Chair, CEO and President, Director
Address: 2980 FAIRVIEW PARK DRIVE, FALLS CHURCH
Signature: /s/ Jennifer C. McGarey, Attorney-in-Fact
Signature date: 13 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NOC transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +34,546
Change %: +20%
Price: $0.000000
Shares after: 206,149
Date: 11 Feb 2026
Ownership: Direct

NOC transaction

Common Stock

Tax liability

Transaction value: $10,434,296
Shares: -15,371
Change %: -7.5%
Price: $678.83
Shares after: 190,778
Date: 11 Feb 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NOC transaction Derivative

Restricted Performance Stock Rights

Award

Transaction value: $0
Shares: +28,785
Change %: +39%
Price: $0.000000
Shares after: 102,064
Date: 11 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 28,785
Exercise price
Footnotes: F1, F2, F3

NOC transaction Derivative

Restricted Stock Rights

Award

Transaction value: $0
Shares: +8,113
Change %: +24%
Price: $0.000000
Shares after: 41,780
Date: 11 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,113
Exercise price
Footnotes: F4, F5, F6

NOC transaction Derivative

Restricted Performance Stock Rights

Options Exercise

Transaction value: $0
Shares: -34,546
Change %: -34%
Price: $0.000000
Shares after: 67,518
Date: 11 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 34,546
Exercise price
Footnotes: F1, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

Footnote F2

The RPSRs acquired include (i) 11,204.16 vested RPSRs with respect to the measurement period ended 12/31/25 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/16/23 that resulted in settlement at 148% of the target award; and (ii) 17,581 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/11/26 with a measurement period ending on 12/31/28. A total of 34,546.16 shares were issued in settlement of the 2023 RPSRs with a measurement period that ended 12/31/25, and the target award amount of 23,342 RPSRs was previously reported in connection with the grant of the 2023 RPSRs.

Footnote F3

Total amount includes (i) 34,546.16 vested RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ended on 12/31/25; (ii) 24,309 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (iii) 25,628 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27; and (iv) 17,581 RPSRs granted under the 2024 LTISP on 2/11/26 with a measurement period ending on 12/31/28.

Footnote F4

Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

Footnote F5

The RSRs were granted under the 2024 LTISP on 2/11/26 and will vest on 2/12/29.

Footnote F6

Total amount includes (i) 10,760 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (ii) 11,155 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (iii) 11,752 RSRs granted under the 2024 LTISP on 2/18/25 that will vest on 2/18/28; and (iv) 8,113 RSRs granted under 2024 LTISP on 2/11/26 that will vest on 2/12/29.

Footnote F7

Total amount includes (i) 24,309 RPSRs granted under the 2011 LTISP on 2/16/24 with a measurement period ending on 12/31/26; (ii) 25,628 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27; and (iii) 17,581 RPSRs granted under the 2024 LTISP on 2/11/26 with a measurement period ending 12/31/28.